Share option award
IXICO plc has issued 1,400,000 share options to members of its broader leadership team, with vesting tied to retention and three-year annual revenue growth, and an exercise price of £0.01, subject to a hold period until the third anniversary of the award.
Select text to share a quote on X · sign in to keep highlights & notes in your IXI notes
9 December 2025 IXICO plc (AIM: IXI) - London, UK. IXICO, a global leader in neuroscience precision medicine and biomarker analytics, using its AI-driven platform to help advance drug development in neurological disorders, today announced that the Company has issued a total of 1,400,000 share options.
These options are awarded to members of the broader leadership of the Company and have vesting criteria aligned with retention and annual revenue growth over 3 years. These options have an exercise price of £0.01 and will be subject to a hold period to the third anniversary of their award.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.